mProbe Taiwan Inc.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
mProbe is aiding oncologists in making informed clinical decisions by providing more comprehensive tumor profiling. And we can deliver more information with less tissue and in less time. With just 2 slides, our patented process allows us to identify over
Founded Year
2017
Unified Business No.
52703902
Status
Active
Number of Employees
0
Total Paid-in
Capital
48,500,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
mProbe believes that the future is personalized medicine. Only by fully understanding the biology of a patient’s cancer can you determine the optimal treatment for that patient and, more to the point, their unique cancer. When an oncologist has access to proteomic and genomic data from FFPE tissue samples, they receive an additional and invaluable profile of the cancer at the molecular level. This allows the doctor to tailor the treatment directly to the cancer.
